Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus

NCT00526513 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
188
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi